PASITHEA THERAPEUTICS CORP. Investment Income, Interest and Dividend
PASITHEA THERAPEUTICS CORP. (KTTA) reported Investment Income, Interest and Dividend of $410.42 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterestAndDividend · last filed 2026-08-14
- PASITHEA THERAPEUTICS CORP. investment income, interest and dividend for the quarter ending 2026-06-30 was $410.42K, a 654.11% increase year-over-year.
- PASITHEA THERAPEUTICS CORP. investment income, interest and dividend for the quarter ending 2026-03-31 was $450.34K, a 853.20% increase year-over-year.
- PASITHEA THERAPEUTICS CORP. investment income, interest and dividend for the quarter ending 2025-12-31 was $182.13K, a 126.29% increase year-over-year.
- PASITHEA THERAPEUTICS CORP. investment income, interest and dividend for the quarter ending 2025-09-30 was $43.40K, a 42.20% decline year-over-year.
- PASITHEA THERAPEUTICS CORP. investment income, interest and dividend for fiscal 2025 was $327.19K, a 22.68% decline from fiscal 2024.
- PASITHEA THERAPEUTICS CORP. investment income, interest and dividend for fiscal 2024 was $423.18K, a 1.88% increase from fiscal 2023.
- PASITHEA THERAPEUTICS CORP. investment income, interest and dividend for fiscal 2023 was $415.37K.
| Period end | Investment Income, Interest and Dividend 3 month | Investment Income, Interest and Dividend 6 month | Investment Income, Interest and Dividend 9 month | Investment Income, Interest and Dividend 12 month |
|---|---|---|---|---|
| 2026-06-30 | $410.42K 10-Q · filed 2026-08-14 | $860.75K 10-Q · filed 2026-08-14 | $1.04M derived: sum of 3 quarters · filed 2026-08-14 | $1.09M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $450.34K 10-Q · filed 2026-05-15 | $632.47K derived: sum of 2 quarters · filed 2026-05-15 | $675.86K derived: sum of 3 quarters · filed 2026-05-15 | $730.29K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $182.13K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $225.52K derived: sum of 2 quarters · filed 2026-03-30 | $279.95K derived: sum of 3 quarters · filed 2026-08-14 | $327.19K 10-K · filed 2026-03-30 |
| 2025-09-30 | $43.40K 10-Q · filed 2025-11-13 | $97.82K derived: sum of 2 quarters · filed 2026-08-14 | $145.06K 10-Q · filed 2025-11-13 | $225.55K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $54.42K 10-Q · filed 2026-08-14 | $101.67K 10-Q · filed 2026-08-14 | $182.15K derived: sum of 3 quarters · filed 2026-08-14 | $257.23K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $47.24K 10-Q · filed 2026-05-15 | $127.73K derived: sum of 2 quarters · filed 2026-05-15 | $202.80K derived: sum of 3 quarters · filed 2026-05-15 | $317.21K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $80.48K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $155.56K derived: sum of 2 quarters · filed 2026-03-30 | $269.97K derived: sum of 3 quarters · filed 2026-03-30 | $423.18K 10-K · filed 2026-03-30 |
| 2024-09-30 | $75.08K 10-Q · filed 2025-11-13 | $189.48K derived: sum of 2 quarters · filed 2025-11-13 | $342.70K 10-Q · filed 2025-11-13 | $515.53K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $114.41K 10-Q · filed 2025-08-14 | $267.63K 10-Q · filed 2025-08-14 | $440.45K derived: sum of 3 quarters · filed 2025-08-14 | $572.19K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $153.22K 10-Q · filed 2025-05-15 | $326.04K derived: sum of 2 quarters · filed 2025-05-15 | $457.78K derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | $172.82K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $304.56K derived: sum of 2 quarters · filed 2025-03-24 | $415.37K 10-K · filed 2025-03-24 | |
| 2023-09-30 | $131.74K 10-Q · filed 2024-11-13 | $242.54K 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |